AVLIX
Price
$9.50
Change
+$0.04 (+0.42%)
Updated
Jul 31 closing price
Net Assets
1.97B
RMEBX
Price
$64.44
Change
+$0.03 (+0.05%)
Updated
Jul 31 closing price
Net Assets
118.05B
Interact to see
Advertisement

AVLIX vs RMEBX

AVLIX vs RMEBX Comparison Chart in %
View a ticker or compare two or three
VS
AVLIX vs. RMEBX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AVLIX is a Hold and RMEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMEBX has more cash in the bank: 118B vs. AVLIX (1.97B). AVLIX pays higher dividends than RMEBX: AVLIX (1.48) vs RMEBX (0.99). AVLIX was incepted earlier than RMEBX: AVLIX (29 years) vs RMEBX (12 years). RMEBX (1.07) is less costly to investors than AVLIX (0.78). AVLIX is a more actively managed with annual turnover of: 55.00 vs. RMEBX (30.00). RMEBX has a lower initial minimum investment than AVLIX: RMEBX (250) vs AVLIX (5000000). AVLIX annual gain was more profitable for investors over the last year : 18.45 vs. RMEBX (8.96). RMEBX return over 5 years is better than : 36.13 vs. AVLIX (8.90).
AVLIXRMEBXAVLIX / RMEBX
Total Expense Ratio0.751.0770%
Annual Report Gross Expense Ratio0.781.0773%
Fund Existence29 years12 years-
Gain YTD17.8449.416190%
Front LoadN/AN/A-
Min. Initial Investment50000002502,000,000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.97B118B2%
Annual Yield % from dividends1.480.99149%
Returns for 1 year18.458.96206%
Returns for 3 years24.3332.6375%
Returns for 5 years8.9036.1325%
Returns for 10 years39.9790.6444%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
RJDI29.260.05
+0.17%
RJ Eagle GCM Dividend Select Income ETF
PBJN30.850.04
+0.14%
PGIM S&P 500 Buffer 20 ETF - Jun
EUO30.170.02
+0.07%
ProShares UltraShort Euro
PMM6.24-0.03
-0.48%
Putnam Managed Municipal Income
IHE101.62-0.84
-0.82%
iShares US Pharmaceuticals ETF